Strid Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Strid Group's LLY Position: Q1 2026 in Review
Strid Group increased its Eli Lilly (LLY) stake by 7.3% in Q1 2026, buying an estimated $24.3K and bringing the position to 353 shares worth $325K. The position accounts for 0.04% of the portfolio, ranked #63.
Strid Group first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. The position peaked at $354K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Strid Group held 353 shares of Eli Lilly worth $325K as of Q1 2026.
- Strid Group bought 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
- Eli Lilly made up 0.04% of Strid Group's portfolio in Q1 2026, its #63 holding.
- Strid Group first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
- Strid Group's Eli Lilly position peaked at $354K in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Strid Group's 13F filing for Q1 2026, filed 29 Apr 2026.